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ABSTRACT
Introduction Knee osteoarthritis (OA) is a prevalent 
condition with associated high disability and healthcare 
costs. Evidence of major gaps in the implementation of 
evidence- based interventions in people with knee OA led 
several healthcare systems to implement models of care 
(MoCs) in order to improve knowledge translation and 
guaranty their economic sustainability. Nevertheless, there 
are few studies that analyse the existing body of evidence 
of MoCs for patients with knee OA in primary healthcare 
settings. Therefore, we aim to identify MoCs developed for 
patients with knee OA implemented in primary healthcare 
and, analyse their core components and outcomes. 
This scoping review will create knowledge about the 
components and outcomes of these MoCs which, in the 
future, will facilitate their transferability to practice.
Methods and analysis We will include studies that 
developed and implemented an MoC for people with 
knee OA in primary healthcare. We will use the PCC 
mnemonic, being ‘Population’—people with Knee OA, 
‘Concept’—the MoCs and ‘Context’—the primary 
healthcare setting. We will conduct the search on PubMed, 
EMBASE, Cochrane Central Register of Controlled Trials, 
Scopus, Web of Science Core Collection, as well as 
grey literature databases and relevant institutions and 
organisations websites, for articles published after 2000. 
Two independent reviewers will screen titles and abstracts 
followed by a full- text review to assess papers regarding 
their eligibility. We will evaluate the methodological quality 
of the included studies with the Mixed Methods Appraisal 
tool and apply a data abstraction form to describe and 
interpret the evidence.
Ethics and dissemination As a secondary analysis, this 
scoping review does not require ethical approval. Findings 
will be published in peer- review journal, presented in 
scientific conferences and as a summary through primary 
healthcare units.
INTRODUCTION
Osteoarthritis (OA) affects approximately 250 
millions of people worldwide,1 and is respon-
sible for 9.6 million years lived with disability.2 
Alongside the impairments in physical func-
tion,3 people with OA often experience 
chronic pain, depression and sleeping prob-
lems.4 Worldwide, healthcare costs related to 
OA represent approximately 0.9% of national 
healthcare systems,5 representing 1%–2.5% 
of the Gross Domestic Product (GDP) of 
high- income countries.6
The knee is the most affected joint and 
it is responsible for approximately 85% of 
the burden of OA.2 The worldwide increase 
of obesity, alongside with the proportion of 
people with low levels of physical activity, are 
associated with the rising prevalence and inci-
dence of knee OA.7
There is no known cure for OA. Currently, 
evidence- based approaches aim to improve 
joint function and patients’ quality of life, 
relieve pain and modify risk factors for 
disease progression. Clinical practice guide-
lines recommend exercise, education, 
self- management and healthy weight main-
tenance as core interventions for knee OA, 
during all stages of this disease. Pharmaco-
logical management is recommended for 
symptom control, and total knee arthroplasty 
(TKA) is considered a latter option, when 
quality of life is significantly impaired, even 
Strengths and limitations of the study
 ► To our knowledge, this is the first scoping review 
that aims to map the literature about models of care 
developed and implemented for patients with knee 
osteoarthritis.
 ► We will undertake a comprehensive search strat-
egy for published and unpublished studies in 
peer- reviewed journals databases, grey literature 
databases, handsearch in relevant journals, organ-
isation and institution websites and conference pro-
ceedings, with the support of a research librarian.
 ► This scoping review is limited to articles written in 
English, Spanish and Portuguese, since 2000.
 ► The quality appraisal of the included studies, al-
though not common on scoping reviews, will provide 
a better interpretation of the results and will identify 
the gaps in evidence in this topic.
 ► This scoping review will generate hypothesis for the 
development of new models of care and support fu-
ture intervention research studies.
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with the implementation of conservative interventions.8 9 
Although TKA is considered to be a cost- effective inter-
vention,10 patient- reported outcomes highlight its short-
comings. Evidence reveals that 5% of patients report 
postoperative complications,11 50% report adverse events 
in the first year after surgery,12 20%–34% report dissatis-
faction with surgery,13 and 3%–5% need surgery revision 
in less than 10 years.14 Furthermore, the mortality rate 
associated with TKA is approximately 0.2%–0.37%.15
Despite international recommendations, evidence 
across several countries report that conservative non- 
pharmacological interventions are offered to less than 
50% of patients.16 17 Moreover, TKA incidence rate 
has been rising exponentially in the Organisation for 
Economic Co- operation and Development (OECD) 
countries, for patients both above and below 65 years old. 
The reported annual growth rate of 5.5% is dispropor-
tional even when the epidemiological changes are taken 
into account.18 Furthermore, qualitative studies reveal 
that healthcare professionals see OA as a trivial condition 
with an unavoidable progression, and often believe that 
conservative treatments lack efficacy.19
Taking this data into account, there are major gaps in 
the translation of evidence to practice, and the care of 
patients with OA has been characterised by symptom- 
driven and segmented interventions,20 centred on phar-
macological,16 17 surgical options.21 The complex and 
multidomain target for knee OA treatment can only be 
achieved by person- oriented intervention models that are 
multidisciplinary, if needed, and include a timely integra-
tion of evidence- based interventions.20 This knowledge 
has driven national health policies in several countries to 
create strategies to improve intervention outcomes, guar-
antee the sustainability of healthcare systems and the cost- 
effectiveness of interventions of patients with OA.22 These 
strategies encompass the implementation of models of 
care (MoCs) that are used as facilitators to bridge the 
gap between evidence and care delivery and practice, 
by describing not only the principles of care for a given 
condition (what to do), but also to guide how these prin-
ciples can be implemented in a local setting (the ‘how’).23
MoCs for musculoskeletal diseases are showing prom-
ising results in overall patient satisfaction with care,24 
improvement of patient- level outcomes and adherence 
to guidelines recommendations,25 and appropriate use of 
medication and reduction of absence from work.26
Several MoCs for OA have been implemented and 
published worldwide,24–27 mainly in primary healthcare 
settings. Usually, MoCs are complex interventions thus, 
its transferability into practice is challenging due to 
their context dependency. Moreover, in 2018 a group of 
researchers and clinicians established the ‘Joint Effort 
Initiative’, endorsed by Osteoarthritis Research Society 
International, which mission includes the investigation 
of the most effective OA Management Programmes, that 
are MoCs for OA, and the development of long- term 
strategies for effective implementation in different socio-
economic and cultural environments. The first action of 
this initiative was to identify and prioritise future work, 
with a survey with delegates with known interest on OA 
Management Programmes. The highest priority ranked 
action statement identified was ‘to establish guidelines 
for the implementation of different OA Management 
Programmes to ensure consistency of delivery and adher-
ence to international best practice MoC’.28 Therefore, 
creating knowledge of and clarifying which intervention 
components have been included in the MoCs, as well 
as exploring their outcomes is paramount and needed 
worldwide.
Few studies have synthesised evidence on MoCs for OA. 
The narrative review by Allen et al.2929 shares some prelim-
inary evidence about the characteristics of selected MoCs 
designed for patients with OA. This is, to our knowl-
edge, the only study that synthesised the evidence on this 
topic. This review identified several MoCs for prevention, 
management in the disease continuum and specific for 
advanced OA, namely directed for total joint replacement 
surgery. The authors concluded that there are emerging 
efforts in multiple countries to implement MoCs, mostly 
focused on non- pharmacological interventions. Addi-
tionally, it is concluded that there is a need to examine 
the impact of these MoCs, and to explore how this MoCs 
can be adapted and implemented in other contexts.29 
Due to its inherent methodological limitations, such as 
the absence of a search strategy, methodological quality 
assessment of the included studies and a standardised 
method for data extraction, it is not possible to replicate 
this review nor to understand how studies were selected. 
Notwithstanding its importance, this study provides a 
biased depiction of the literature of MoCs developed for 
patients with OA.
With this scoping review, we aim to map the existing 
literature of MoCs developed for people with knee OA 
through a systematic methodology. Our primary objec-
tive is to identify MoCs developed for patients with knee 
OA in primary healthcare and describe their compo-
nents. The secondary objectives are to describe the 
outcomes of MoCs and to identify specific aspects of the 
context reported related with the implementation of the 
MoC. These context- related aspects, which can influ-
ence the success and transferability of the MoCs, will be 
divided in three categories: external (e.g., supportive 
national/local policies, governmental financial incen-
tives, dominant paradigms in society as evidence- based 
practice or patient- centred care, support of stake-
holders), organisational (e.g., presence of a culture of 
innovation, leadership characteristics, organisational 
readiness, resources available and professional relation-
ships among team and patients) and population- level 
(e.g., specific geographic areas with different access to 
health services, subpopulations with special sociodemo-
graphic and clinical characteristics).30 Although quali-
tative assessment is not usually performed on scoping 
reviews,31 32 we will include it to describe the quality of 
research in this field.
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METHODS AND ANALYSIS
A scoping review is a valid, comprehensive and transparent 
method for mapping the body of evidence underpinning 
a research area, main sources and type of evidence avail-
able. Scoping reviews are mainly made for complex and 
heterogeneous research topics or for those which were 
not previously comprehensively reviewed.32 33 Given the 
stated objectives of this review, the topic of interest is the 
identification, mapping, reporting and discussion of the 
characteristics of MoCs. Therefore, our purpose is better 
aligned with a scoping review, instead of systematic review, 
considering the criteria described by Munn et al34
The methodology of this scoping review will be guided 
by established methodological frameworks, as outlined by 
Arksey and O’Malley33, and enhanced by Levac et al31 and 
Joanna Briggs Institute (JBI).35 The Preferred Reporting 
Items for Systematic Reviews and Meta- Analysis extension 
(PRISMA) for Scoping Reviews will guide the develop-
ment of the scoping review to ensure transparency of the 
results uptake.36 To our knowledge, and after a search in 
relevant databases, this is the first protocol for a scoping 
review that aim to identify the MoCs developed and 
implemented for people with knee OA.
Research questions
According to the objectives previously formulated, 
this review will attain to answer the following research 
questions
1. Which MoCs have been implemented for non- 
institutionalised patients with knee OA attending pri-
mary healthcare units?
2. What are the core components included in the MoCs 
(these include, but are not limited to, interventions 
and their characteristics, healthcare professionals in-
volved, programmes duration, funding)?
3. What are the MoCs outcomes and how have they been 
measured (patient- level outcomes, system- level out-
comes and implementation outcomes)?
4. Which are the aspects of the included MoCs that are 
context- specific at external, organisational and popu-
lation level (as described in the introduction section)?
Identification of the relevant literature
Inclusion criteria
To guide the identification and inclusion of the studies 
we will use the mnemonic ‘PCC’ referring to Population, 
Concept and Context, as proposed by JBI.35
Population
We will consider studies that included non- institutionalised 
adults (that live in the community, and are not residents/
inpatients in any institution, like hospitals, psychiatric 
centres, nursing homes, military institutions or prisons), 
diagnosed with knee OA who have not undergone, or 
scheduled, TKA. Studies that involve patients with other 
types of arthritis or patients with OA in multiple joints 
will be included if more than 50% of the patients have 
diagnosis of knee OA.
Concept
The concept of interest in this review is MoCs designed 
for patients with knee OA. In this study, we will use the 
definition by Briggs et al that defines an MoC as ‘an 
evidence- informed policy or framework that outlines the 
optimal manner in which condition- specific care should 
be made available and delivered to consumers at a system 
level’.23 Therefore, ‘a MoC aims to describe the principles 
of care for a given condition (the ‘what’) as well as guid-
ance on how those principles could be implemented in a 
local setting (the ‘how’)’. A distinction should be made 
between MoCs, clinical guidelines and models of service 
delivery. MoC serve as guides that complement clinical 
practice guidelines, describing how best evidence can be 
implemented as a sector- wide model of service delivery 
by clinicians, consumers and health systems across the 
disease continuum, tailored to the specificities of local 
context. Thus, a model of service delivery converts the 
principles of an MoC into operational activity and oper-
ational recommendations, relevant to the local context, 
modes of service delivery and evaluation, considering 
resources, infrastructure and workforce capacity require-
ments. As mentioned, the concept of interest of this 
scoping review is MoC, and we will only consider the 
model of service delivery of a specific MoC to describe its 
organisational components.23
To guide the inclusion of the studies in this review 
we develop operational a priori criteria to distinguish a 
model of care from other types of interventions based on 
The Framework to Evaluate Musculoskeletal MoC, Briggs 
et al37 and Eyles et al28 .23 28 37 Only studies that address 
the implementation in a real- world setting of MoC’s and 
that fulfil all the following criteria will be considered for 
inclusion:
 ► Defines the optimal care manner to deliver care 
for people with OA, with an underlying evidence- 
informed strategy, framework or pathway.
 ► Describes the operationalisation of the MoC, for 
example, who deliver care, when and where care is 
best delivered and how it is to be delivered.
 ► The MoC is tailored according to context.
 ► Care is coordinated, with longitudinal progression 
and reassessments.
 ► The implementation of the MoC has patient- level, 
organisational- level and/or implementation- level 
goals.
In this scoping review, we will consider the identified 
MoC as the unit of interest thus, several studies that 
report the outcomes of the same MoC will be considered.
According to the stated research questions as well as 
the recommendations for implementation of MoC’s,37 
we will a priori include studies that describe, but are not 
limited to: (1) Which MoC was implemented: identifica-
tion of MoC and/or frameworks/theory used; (2) What 
and how care is provided, and by whom: underlying inter-
ventions at patient level, professionals training, services 
involved, organisation of care, among others; (3) How the 
MoC is assessed and what were its outcomes at patient’s 
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level (e.g., pain, function or quality of life, satisfaction, 
collected with self- reported questionnaires or interview 
questionnaires or performance measures), at system level: 
(e.g., rate of referral or prescription for exercise, rate of 
prescribed exams, healthcare costs, waiting times, quality 
indicators, perceptions/perspectives of stakeholders) and 
implementation outcomes (e.g., acceptability, adoption, 
feasibility, fidelity, penetration, sustainability) and (4) 
What are the aspects, if any, of the MoC that are context- 
specific at external, organisational and population level, 
as described in introduction section. We will include 
MoCs that consider non- pharmacological interventions 
(for example, exercise, patient education, behavioural 
change programmes, self- efficacy and self- management 
programmes), combined or not with pharmacological 
interventions, integrated in an MoC. We will exclude 
MoCs that focus only on pharmacological interventions, 
or that includes surgery or complementary and alterna-
tive medicine interventions.
Context
This review will be focused on primary healthcare 
context. WHO defines primary healthcare as a ‘whole- 
of- society approach to health’.38 According with guide-
lines recommendations, primary care is the most relevant 
setting worldwide for both research and management of 
patients with OA for prevention and across the disease 
continuum.8 9
We will include studies that have implemented MoCs 
focused on primary care services, but we will consider also 
MoCs that include interventions at other levels of health-
care delivery as long as it includes primary care services 
in the patient’s pathway. The inclusion of primary health-
care in the pathway may be referred as the first contact 
with the healthcare system, for direct provision of care, 
point of referral to other levels of care or services or 
continuity of care. Primary care services may cover all the 
full continuum of health promotion and disease preven-
tion, treatment and rehabilitation, delivered at individual 
or community- oriented approach. Thus, MoCs that 
consider in the pathway services such as, but not limited 
to, community pharmacies, physiotherapy and nutrition 
outpatient services, physical activity community services 
as well as hospitals or other secondary care settings linked 
with primary care will be included.38
Types of sources
We will include quantitative studies with comparative 
(randomised controlled, cohort, quasi- experimental) 
and non- comparative methods (narrative, policy reports, 
audit) related with the implementation of MoCs for 
patients with knee OA, that report outcomes of the imple-
mentation of the MoC. Qualitative or mixed- methods 
study designs will also be considered only if they report 
outcomes of the implementation for example, qualitative 
evaluation studies.
We will exclude studies that aim to test clinical effec-
tiveness or efficiency of specific clinical interventions 
that do not undertake implementation interventions. In 
order to distinguish typical clinical intervention trials and 
implementation intervention trials related to MoCs (e.g., 
pilot studies, cluster or pragmatic randomised controlled 
trials) during title and abstract screening, we will consider 
studies for full text screening when the experimental 
group is compared with usual care, at the same or at 
another healthcare unit, wait list or no treatment when-
ever the title and abstract suggests an underlying MoC.39 
We will assume overinclusion of clinical intervention 
studies for full- text screening whenever doubts arise.
Literature published between 2000 and 2020 written 
in English, Portuguese or Spanish, in peer- reviewed and 
grey literature will be included in order to capture the 
most recent evidence on the implementation of MoC 
aligned with current paradigms of healthcare delivery.40
Search strategy
We will run the search query in PubMed, EMBASE 
and Cochrane Central Register of Controlled Trials 
(CENTRAL), Scopus (including conference proceed-
ings), Web of Science Core Collection (including confer-
ence proceedings). Then, we will conduct a hand search 
in relevant peer- reviewed journals: Osteoarthritis and 
Cartilage, Best Practice and Research Clinical Rheuma-
tology, BMC Musculoskeletal Disorders, Arthritis Care 
and Research, Implementation Science, Health Services 
and Delivery Research, JBI Evidence Synthesis and BMC 
Health Services Research.
We will perform the search in Open Grey, Grey Litera-
ture Report databases and MedNar search engine to iden-
tify grey literature records. We will also search websites 
of relevant institutions and organisations, such as WHO, 
Arthritis Australia, American College of Rheumatology, 
Osteoarthritis Research Society International, European 
League Against Rheumatism, Agency for Clinical Inno-
vation Musculoskeletal Network, Arthritis Community 
Research & Evaluation Unit, National Institute for Health 
Research, and Bone and Joint Initiative.
We will screen the reference lists of the selected arti-
cles for inclusion to identify additional potentially eligible 
primary studies. Additionally, we will check reference lists 
of previous published reviews. We will contact authors 
of the included studies to clarify any questions we might 
have about their published reports and to seek unpub-
lished data related to the MoC. Different reports of the 
same MoC will be collated, as each MoC is the unit of 
interest.41
We undertook a preliminary search in PubMed in 
September of 2020, which was built according to the 
‘PCC’ mnemonic. The search terms included ‘osteo-
arthritis’, ‘models of care’ and ‘primary care’ and their 
synonyms, in title or abstract. We used the text words of 
relevant articles on this topic and the index terms used 
to describe these articles to develop a full search strategy 
(online supplemental file). As MoC are often poorly 
defined in the literature, and used interchangeably, as 
‘service improvement frameworks’, ‘models of service 
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delivery’, ‘clinical frameworks’ or ‘care pathways’, we will 
use a broad search strategy to cover all relevant studies. 
We will adapt the search strategy to each of the included 
databases. This process will be held in collaboration with 
a research librarian. We will conduct the searches from 
May to June 2021.
Study selection
Two independent reviewers (DC and LAG) will screen 
abstracts and titles of the search records. We will adopt 
maximum sensitivity during title and abstract screening, 
and retrieve full texts for all records included by at least 
one reviewer. The review team will perform a pilot testing 
of source selectors with the selection of a sample of 25 
random titles/abstracts. We will screen this sample using 
the defined eligibility criteria, discussing discrepancies 
and making any necessary modifications. Screening 
will start only when we achieve an agreement of 75% 
or more.41 For full- text screening we will note specific 
reasons for exclusion.
All identified articles will be collated and uploaded, 
duplicates will be removed, potentially relevant papers 
will be extracted in full and their citation details will be 
uploaded using EndNote X7.8 (Clarivate Analytics, USA). 
We will report a narrative description of the process of 
the search in the final scoping review accompanied by a 
PRISMA flow diagram.36
As previously stated, the unit of interest is the identified 
MoC, therefore we expect that, during the study selection, 
we will identify more than one study for the same MoC. 
Thus, all papers with a MoC that respects the inclusion 
criteria for population and context will be investigated 
for additional papers and then aggregated. In the end of 
full- text screening, we will collate information of different 
single studies related with the same MoC.
Data charting
Two reviewers (DC and LAG) will independently complete 
a standard data abstraction form to extract data from each 
study using a pilot- tested data abstraction form. Charting 
is a technique for organising and interpreting the data 
by screening, charting and sorting material according to 
the main issues and themes. The reviewers will apply the 
pilot- test data abstraction form in at least five articles to 
test and ensure consistency of the form in line with the 
purpose of the study, as presented in table 1. Changes will 
be made and discussed with the team prior to extracting 
data from the remaining articles. As an iteractive process, 
during the data extraction some items can be added 
according with studies found.32 We will detail these modi-
fications in full in the scoping review.
Quality assessment
Performing quality assessment is not common and is also 
a controversial issue in scoping reviews. The absence of 
quality appraisal is usually referred as a methodological 
limitation,42 and, at the same time, a necessary compo-
nent.43 By qualitatively appraising the included studies, 
we will be able to map the quality of the literature in this 
field. Therefore, not only will we identify where research 
is lacking, but also the gaps in evidence base, identify the 
types of available evidence, and how research has been 
conducted in this area.34 Additionally, quality appraisal 
is of paramount importance for the interpretation 
and dissemination of the results of this scoping review, 
enhancing their usefulness to practice, policy- making and 
for future research.44
Two independent reviewers will analyse the method-
ological quality of the retrieved studies using the Mixed 
Methods Appraisal Tool, 2018 version, since we expect to 
find a wide range of study types. This is a validated tool 
to evaluate qualitative research, randomised controlled 
trials, non- randomised studies, quantitative description 
studies and mixed- methods studies. Any disagreements 
between reviewers will be solved by consensus or decision 
of a third reviewer. We will report results in a narrative 
form and in a table that will contain the accomplishment 
information of each item of the checklists, described as 
Table 1 Data extraction according to scoping review 
research questions









1: identification of 
the MoC
MoC Identification (name, if applicable)
Country
Population addressed and sample size, 
including proportion of participants 
with Knee OA (n/% of total)
Research 
question 2: core 
components
Theory/framework
Interventions components and their 
characteristics
Organisational components (eg, 
healthcare professionals involved, 
workforce capacity, programmes 
duration, funding, care coordination)
Research question 
3: outcomes and 
outcome measures 
used
Outcomes addressed and outcome 
measures
Main results of MoC (outcomes at 
organisation and patient level
Evaluation of implementation success 
(if applicable)
Research question 
4: context- specific 
components
Context- specific external factors
Context- specific organisational factors
Context- specific population factors
MoC, models of care; OA, osteoarthritis.
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‘yes’, ‘no’ and ‘can’t tell’.45 This appraisal will provide 
a structured and thorough analysis the range of quality 
of studies of knee OA MoCs that has been published, 
leading to a better interpretation of the results.
Synthesis and presentation of results
We will perform a descriptive qualitative content analysis 
that will be presented in a tabular form, aligned with the 
objectives and research questions of this scoping review. 
This will include the identification of the MoC, the core 
intervention components, professionals involved and 
inherent training, services involved, organisation compo-
nents, context- related specificities, outcome measures 
used and outcomes at organisational and patient level 
and evaluation of implementation success. We will report 
also as quantitative data, using a descriptive numerical 
summary, the overall number of studies, study designs, 
years of publication, types of intervention, characteristics 
of the study population and geographical distribution of 
studies. Meta- analysis is not planned.
Additionally, a narrative summary will accompany the 
tabulated results and will describe how the results relate 
to the research questions and objectives. As stated before, 
the data extraction may be updated during the data 
extraction process.
Consultation with relevant stakeholders
Two members of the research team (EBC and AMR) have 
developed and implemented MoCs for musculoskeletal 
diseases and will be involved throughout the analysis 
process. This involvement will provide additional sources 
of information, perspectives, high level of meaning 
content, expertise and it will enhance the applicability of 
this scoping study.
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